Cannabinoid-induced apoptosis in immune cells as a pathway to immunosuppression (full - 2010)http://www.ncbi.nlm.nih.gov/pmc/arti...8/?tool=pubmed
Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20561509
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
The endocannabinoid system in sepsis – a potential target to improve microcirculation? (full – 2011) http://www.signavitae.com/articles/r...crocirculation
Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation (abst – 2011)http://www.ncbi.nlm.nih.gov/pubmed/21279327
Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis (full – 2012) http://ccforum.com/content/16/2/R47
Cannabinoid receptor 1 inhibition causes seizures during anesthesia induction in experimental sepsis. (full – 2012)http://journals.lww.com/anesthesia
analgesia/Fulltext/2012/06000/Cannabinoid_Receptor_1_Inhibition_Causes_Seizures. 12.aspx
Cannabinoid Receptor 2 Protects against Acute Experimental Sepsis in Mice (full – 2013) http://www.hindawi.com/journals/mi/2013/741303/
Targeting the Endocannabinoid System to Treat Sepsis (review – 2013) http://www.signavitae.com/articles/r...o-treat-sepsis
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23382309
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis (full – 2014) http://www.hindawi.com/journals/mi/2014/978678/
Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080545/
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24644287
Novel approaches to the development of anti-sepsis drugs (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24697209
Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25425209
Treatment with cannabidiol reverses oxidative stress parameters, cognitive impairment and mortality in rats submitted to sepsis by cecal ligation and puncture (abst – 2010) http://www.ncbi.nlm.nih.gov/pubmed/20561509
Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
The endocannabinoid system in sepsis – a potential target to improve microcirculation? (full – 2011) http://www.signavitae.com/articles/r...crocirculation
Honokiol rescues sepsis-associated acute lung injury and lethality via the inhibition of oxidative stress and inflammation (abst – 2011)http://www.ncbi.nlm.nih.gov/pubmed/21279327
Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis (full – 2012) http://ccforum.com/content/16/2/R47
Cannabinoid receptor 1 inhibition causes seizures during anesthesia induction in experimental sepsis. (full – 2012)http://journals.lww.com/anesthesia
analgesia/Fulltext/2012/06000/Cannabinoid_Receptor_1_Inhibition_Causes_Seizures. 12.aspx
Cannabinoid Receptor 2 Protects against Acute Experimental Sepsis in Mice (full – 2013) http://www.hindawi.com/journals/mi/2013/741303/
Targeting the Endocannabinoid System to Treat Sepsis (review – 2013) http://www.signavitae.com/articles/r...o-treat-sepsis
Inhibition of endocannabinoid degradation in experimental endotoxemia reduces leukocyte adhesion and improves capillary perfusion in the gut (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23382309
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis (full – 2014) http://www.hindawi.com/journals/mi/2014/978678/
Palmitoylethanolamide stimulates phagocytosis of Escherichia coli K1 by macrophages and increases the resistance of mice against infections (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080545/
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24644287
Novel approaches to the development of anti-sepsis drugs (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24697209
Δ9 Tetrahydrocannabinol attenuates Staphylococcal enterotoxin B-induced inflammatory lung injury and prevents mortality in mice by modulation of miR-17-92 cluster and induction of T-regulatory cells (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25425209